Wide Ranks

LBPH

Longboard Pharmaceuticals, Inc.

59.96

Top Statistics
Market Cap 2 B Forward PE -21.90 Revenue Growth 0.00 %
Current Ratio 15.97 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -23.52 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 288 M Total Cash Per Share 7.39 Total Debt 3 M
Total Debt To Equity 1.36 Current Ratio 15.97 Book Value Per Share 7.05
All Measures
Short Ratio 127.00 % Message Board Id finmb_656470663 Shares Short Prior Month 5 M
Return On Equity -0.4666 City La Jolla Uuid 3613b707-ae0b-3b49-aa53-370148927a51
Previous Close 59.95 First Trade Date Epoch Utc 1 B Book Value 7.05
Beta 1.09 Total Debt 3 M Volume 855313
Price To Book 8.50 Fifty Two Week Low 3.60 Total Cash Per Share 7.39
Shares Short Previous Month Date 1 B Target Median Price 60.00 Max Age 86400
Sand P52 Week Change 0.3133 Target Mean Price 64.67 Net Income To Common -76344000
Short Percent Of Float 0.0653 Implied Shares Outstanding 39 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 897950 Average Volume10days 897950
Total Cash 288 M Next Fiscal Year End 1 B Held Percent Insiders 0.0120
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 59.95 Target Low Price 60.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 50.95 Open 59.96 Free Cashflow -36367248
State CA Dividend Yield 0.00 % Return On Assets -0.3072
Time Zone Short Name EST Trailing Eps -2.25 Day Low 59.94
Address1 4275 Executive Square Shares Outstanding 34 M Price Hint 2
Target High Price 80.00 Website https://www.longboardpharma.com 52 Week Change 14.95
Average Volume 1 M Forward Eps -2.82 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 1571.70 % Is_sp_500 False
Regular Market Day High 59.98 Profit Margins 0.00 % Debt To Equity 1.36
Fifty Two Week High 59.98 Day High 59.98 Shares Short 1 M
Regular Market Open 59.96 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0494 Operating Cashflow -65931000
Currency USD Time Zone Full Name America/New_York Market Cap 2 B
Is_nasdaq_100 False Zip 92037 Quote Type EQUITY
Industry Biotechnology Long Name Longboard Pharmaceuticals, Inc. Regular Market Day Low 59.94
Held Percent Institutions 1.22 Current Price 59.96 Address2 Suite 950
Enterprise To Ebitda -23.52 Financial Currency USD Current Ratio 15.97
Industry Disp Biotechnology Number Of Analyst Opinions 6 Country United States
Float Shares 24 M Two Hundred Day Average 31.89 Enterprise Value 2 B
Forward PE -21.90 Regular Market Volume 855313 Ebitda -87445000
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases.

The company develops bexicaserin (LP352), which has completed Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies.

It also develops LP659, an S1P receptor modulator for the treatment of neurological diseases.

The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020.

Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.